MedTrace Logo

NSABP Biospecimen Discovery Project

NCT01850628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-10-05

No results posted yet for this study

Summary

This study is a biospecimen discovery project that will serve as a pilot for a comprehensive 'omics approach using fresh core biopsy tissue and blood samples for DNA and protein analysis, as well as paired tumor-normal exome DNA and RNA sequencing.

Conditions

Interventions

DRUG

Paclitaxel

BIOLOGICAL

trastuzumab

BIOLOGICAL

pertuzumab

Sponsors & Collaborators

  • Breast Cancer Research Foundation

    collaborator OTHER

  • Washington University School of Medicine

    collaborator OTHER

  • NSABP Foundation Inc

    lead NETWORK

Principal Investigators

  • Norman Wolmark, MD · NSABP Foundation Inc

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2018-06-30
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01850628 on ClinicalTrials.gov